Jazz Pharmaceuticals (JAZZ) Misses Q1 EPS by 3c, Slight Miss on Revenues; Updates FY17 Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DGNX

Go back to Jazz Pharmaceuticals (JAZZ) Misses Q1 EPS by 3c, Slight Miss on Revenues; Updates FY17 Outlook

Jazz Pharmaceuticals (JAZZ) PT Lowered to $174 at Deutsche Bank; 'Decent Q, 2017 shaping up nicely'

May 10, 2017 9:06 AM EDT

Deutsche Bank lowered its price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $174.00 (from $176.00) while maintaining a Buy rating.

... More